Showing results (291-300 of 365) with videos related to

Sort By:
Pageof 37
Immunotargets and Therapy|June 23, 2025
Prognostic Significance of Circulating Immune Subset Counts in Nasopharyngeal CarcinomaHonghui Xie, Lin Zhang, Lizhi Chen, et al.
Immunotargets and Therapy|January 7, 2026
Flow Cytometric Profiling of Peripheral Immune Checkpoints Predicts Prognosis and Reveals PD-1/Treg/IL-10 Crosstalk in B-Cell LymphomaBing Pan, Sijia Li, Ruyu Ye, et al.
Immunotargets and Therapy|November 11, 2025
Understanding and Managing Hyper IgE SyndromesZeynep Meric, Muhammed Aydin, Dilan Demir Gumus, et al.
Immunotargets and Therapy|October 28, 2025
Regulation of Histone Acetylation During Inflammation ResolutionLi Gong, Juan Lei, Yu Zhou, et al.
Immunotargets and Therapy|October 28, 2025
Combination Therapy with Romiplostim, Danazol, and a Thrombopoietin Receptor Agonist for Immune Restoration in Chronic Refractory Immune Thrombocytopenia: A Case SeriesShi-Xuan Wang, Gen-Mei Tan, Zhi-Ming Zou, et al.
Immunotargets and Therapy|September 24, 2025
Anti-CD24 Antibody Plus Liposomal Doxorubicin for the Management of Residual Cancers After Incomplete Radiofrequency AblationJiayun Liu, Bo Sun, Jing Li, et al.
Immunotargets and Therapy|September 24, 2025
Targeting ILT4 to Improve Immunotherapy Efficacy in Solid Tumour: From Bench to BedsideAiqin Gao, Shuyun Wang, Yuping Sun
Immunotargets and Therapy|September 12, 2025
Directed-Complement Activation as a Novel Immunotherapeutic Approach for HER2-Breast CancerCarole Seguin-Devaux, Bianca Brandus, Jean-Marc Plesseria, et al.
Immunotargets and Therapy|September 10, 2025
Efficiency and Safety of HAIC Combined with Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma with Lung Metastasis: A Multicenter Propensity Score Matching AnalysisSong Chen, Ning Wang, Yi Xiao, et al.
Immunotargets and Therapy|September 19, 2025
Prostate Cancer Immunotherapy: Time to Move Beyond Checkpoint InhibitorsMelissa Abel, Aanika Balaji Warner, Fatima Karzai, et al.
Pageof 37